BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38275073)

  • 21. Synthesis of N-phenylsulfonamide derivatives and investigation of some esterase enzymes inhibiting properties.
    Akin Kazancioglu E; Senturk M
    Bioorg Chem; 2020 Nov; 104():104279. PubMed ID: 32980674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
    Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diosmetin derivatives as multifunctional anti-AD ligands: Design, synthesis, and biological evaluation.
    Yang A; Yi X; Zhang H; Shen R; Kou X
    Chem Biol Drug Des; 2024 Apr; 103(4):e14529. PubMed ID: 38670598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.
    Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Grishchenko MV; Lushchekina SV; Astakhova TY; Serebryakova OG; Timokhina EN; Zhilina EF; Shchegolkov EV; Ulitko MV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds.
    Tamaddon-Abibigloo Y; Dastmalchi S; Razzaghi-Asl N; Shahbazi Mojarrad J
    Bioorg Chem; 2024 Jun; 147():107355. PubMed ID: 38657528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N'-(quinolin-4-ylmethylene)propanehydrazides against Alzheimer's disease.
    Kilic B; Dogruer DS
    Drug Dev Res; 2024 May; 85(3):e22183. PubMed ID: 38628078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
    Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
    Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.
    Wu M; Ma J; Ji L; Wang M; Han J; Li Z
    Eur J Med Chem; 2019 Sep; 177():198-211. PubMed ID: 31136894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis and Biological Evaluation of Xanthone Derivatives for Possible Treatment of Alzheimer's Disease Based on Multi-Target Strategy.
    Yang A; Yu Q; Ju H; Song L; Kou X; Shen R
    Chem Biodivers; 2020 Oct; 17(10):e2000442. PubMed ID: 32692899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, molecular docking studies, and biological evaluation of novel alkyl bis(4-amino-5-cyanopyrimidine) derivatives.
    Boualia I; Derabli C; Boulcina R; Bensouici C; Yildirim M; Birinci Yildirim A; Mokrani EH; Debache A
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900027. PubMed ID: 31448454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
    Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
    Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.
    Chaves S; Resta S; Rinaldo F; Costa M; Josselin R; Gwizdala K; Piemontese L; Capriati V; Pereira-Santos AR; Cardoso SM; Santos MA
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32098407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of indole derivatives as Alzheimer inhibitors and their molecular docking study.
    Homoud ZA; Taha M; Rahim F; Iqbal N; Nawaz M; Farooq RK; Wadood A; Alomari M; Islam I; Algheribe S; Rehman AU; Khan KM; Uddin N
    J Biomol Struct Dyn; 2023 Nov; 41(19):9865-9878. PubMed ID: 36404604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitors.
    Ghobadian R; Nadri H; Moradi A; Bukhari SNA; Mahdavi M; Asadi M; Akbarzadeh T; Khaleghzadeh-Ahangar H; Sharifzadeh M; Amini M
    Bioorg Med Chem; 2018 Sep; 26(17):4952-4962. PubMed ID: 30190181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
    Huang L; Miao H; Sun Y; Meng F; Li X
    Eur J Med Chem; 2014 Nov; 87():429-39. PubMed ID: 25282266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.